Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies (Q66850608)
scientific article published on 01 February 1976
Language:
Current Data About Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies
(P31) (Q13442814)
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P304) 653-659
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P407) (Q1860)

(P433) 2
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P478) 37
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P577) Sunday, February 1, 1976
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P1433) (Q326041)
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P1476) "Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies" (language: en)
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1062226%20AND%20SRC:MED&resulttype=core&format=json
(P813) Friday, August 30, 2019

(P2093) C. Jacquillat
(P1545) 1
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

M. Weil
(P1545) 2
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

M. F. Gemon-Auclerc
(P1545) 3
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

V. Izrael
(P1545) 4
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

A. Bussel
(P1545) 5
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

M. Boiron
(P1545) 6
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

J. Bernard
(P1545) 7
(P248)
(P698) 1062226
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1062226
(P813) Thursday, August 18, 2022

other details
description scientific article published on 01 February 1976

External Links
(P356) 10.1002/1097-0142(197602)37:2<653::AID-CNCR2820370207>3.0.CO;2-Q
(P698) 1062226